INTO GERMANY! The German Business Podcast
A Shot in the Arm: Pharma Benefits from a New German Legal
Germany is reforming pharmaceutical regulations to boost domestic production, creating new opportunities for the sector. Eli Lilly and Company is building a $2.5 billion facility, one of the largest investments in the industry, in response to these changes.